The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic Review.
Anticancer treatments
Cancer
Death risk
Depression
Elderly
Quality of life
Suicide
Journal
Clinical practice and epidemiology in mental health : CP & EMH
ISSN: 1745-0179
Titre abrégé: Clin Pract Epidemiol Ment Health
Pays: United Arab Emirates
ID NLM: 101245735
Informations de publication
Date de publication:
2021
2021
Historique:
received:
18
02
2021
revised:
08
09
2021
accepted:
17
11
2021
entrez:
21
4
2022
pubmed:
22
4
2022
medline:
22
4
2022
Statut:
epublish
Résumé
Depression is a common psychiatric problem in the elderly and oncology patients. In elderly people with cancer, depression has a peculiar phenomenology. It has a significant impact on the quality of life. Moreover, it is associated with poor adherence to treatments, increased risk of suicide, and mortality. Nevertheless, the topic of depression in elderly people with cancer remains unexplored. The main goal of this article is to review the literature from the past 20 years on the relationships between depression, cancer, and aging. The methods followed the Prisma model for eligibility of studies. The articles in which the keywords "depression", "cancer", " elderly, aging, or geriatric" were present, either in the text or in the abstract, were selected. 8.056 articles, by matching the keywords "depression and elderly and cancer," were identified. Only 532 papers met the eligibility criteria of search limits and selection process. Out of 532 papers, 467 were considered irrelevant, leaving 65 relevant studies. Out of 65 suitable studies, 39 (60.0%) met our quality criteria and were included. The risk factors associated with depression in elderly people with cancer can be divided into 4 groups: 1) tumor-related; 2) anticancer treatment-related; 3) patients-related; 4) number and type of comorbidity. The main obstacles in diagnosing depression in elderly patients with cancer are the overlap of the symptoms of cancer and side effects of treatment with the symptoms of depression but also the different ways of reporting depressive symptoms of elderly people and the different clinical types of depression. There is a lack of data regarding validated scales to assess depression in geriatric patients with cancer. Any mental illness, specifically co-occurring anxiety and depression, increases the risk of diagnosis delay and anticancer treatment adherence. Cancer and the diagnosis of mental disorders prior to cancer diagnosis correlate with an increased risk for suicide. A non-pharmacological therapeutic approach, pharmacological treatment and/or a combination of both can be used to treat elderly patients with cancer, but a detailed analysis of comorbidities and the assessment of polypharmacy is mandatory in order to avoid potential side-effects and interactions between antidepressants and the other drugs taken by the patients. Future research should be conducted with the aim of developing a modified and adapted assessment method for the diagnosis and treatment of depression in elderly people with cancer in order to improve their clinical outcomes and quality of life.
Sections du résumé
Background
UNASSIGNED
Depression is a common psychiatric problem in the elderly and oncology patients. In elderly people with cancer, depression has a peculiar phenomenology. It has a significant impact on the quality of life. Moreover, it is associated with poor adherence to treatments, increased risk of suicide, and mortality. Nevertheless, the topic of depression in elderly people with cancer remains unexplored.
Objective
UNASSIGNED
The main goal of this article is to review the literature from the past 20 years on the relationships between depression, cancer, and aging.
Methods
UNASSIGNED
The methods followed the Prisma model for eligibility of studies. The articles in which the keywords "depression", "cancer", " elderly, aging, or geriatric" were present, either in the text or in the abstract, were selected. 8.056 articles, by matching the keywords "depression and elderly and cancer," were identified. Only 532 papers met the eligibility criteria of search limits and selection process. Out of 532 papers, 467 were considered irrelevant, leaving 65 relevant studies. Out of 65 suitable studies, 39 (60.0%) met our quality criteria and were included.
Results
UNASSIGNED
The risk factors associated with depression in elderly people with cancer can be divided into 4 groups: 1) tumor-related; 2) anticancer treatment-related; 3) patients-related; 4) number and type of comorbidity. The main obstacles in diagnosing depression in elderly patients with cancer are the overlap of the symptoms of cancer and side effects of treatment with the symptoms of depression but also the different ways of reporting depressive symptoms of elderly people and the different clinical types of depression. There is a lack of data regarding validated scales to assess depression in geriatric patients with cancer. Any mental illness, specifically co-occurring anxiety and depression, increases the risk of diagnosis delay and anticancer treatment adherence. Cancer and the diagnosis of mental disorders prior to cancer diagnosis correlate with an increased risk for suicide. A non-pharmacological therapeutic approach, pharmacological treatment and/or a combination of both can be used to treat elderly patients with cancer, but a detailed analysis of comorbidities and the assessment of polypharmacy is mandatory in order to avoid potential side-effects and interactions between antidepressants and the other drugs taken by the patients.
Conclusion
UNASSIGNED
Future research should be conducted with the aim of developing a modified and adapted assessment method for the diagnosis and treatment of depression in elderly people with cancer in order to improve their clinical outcomes and quality of life.
Identifiants
pubmed: 35444712
doi: 10.2174/1745017902117010295
pii: CPEMH-17-295
pmc: PMC8985471
doi:
Types de publication
Systematic Review
Langues
eng
Pagination
295-306Informations de copyright
© 2021 Massa et al.
Références
J Affect Disord. 2015 Apr 1;175:287-91
pubmed: 25661393
Am J Psychiatry. 1980 Apr;137(4):439-44
pubmed: 7361929
J Affect Disord. 2012 Feb;136(3):212-21
pubmed: 21194754
Cancer. 1994 Oct 1;74(7 Suppl):2107-17
pubmed: 8087778
J Clin Oncol. 2009 Jun 10;27(17):2758-65
pubmed: 19403886
Arch Gen Psychiatry. 2002 Jul;59(7):605-11
pubmed: 12090813
Psychiatr Serv. 1999 Sep;50(9):1158-66
pubmed: 10478901
Nat Rev Cancer. 2005 Aug;5(8):655-62
pubmed: 16056261
Arch Gerontol Geriatr. 2015 Jan-Feb;60(1):9-15
pubmed: 25266607
Oncologist. 2009 Jan;14(1):60-6
pubmed: 19144682
Psychooncology. 2017 Jan;26(1):15-21
pubmed: 26913707
J Clin Oncol. 2009 Feb 10;27(5):699-705
pubmed: 19114706
J Am Geriatr Soc. 2004 Jan;52(1):106-11
pubmed: 14687323
J Thyroid Res. 2012;2012:590648
pubmed: 22220285
Am J Psychiatry. 1999 Aug;156(8):1182-9
pubmed: 10450258
Arch Intern Med. 1988 Sep;148(9):1929-36
pubmed: 3415405
J Clin Oncol. 2010 Jan 10;28(2):348-56
pubmed: 19996030
J Pain Symptom Manage. 1994 Jul;9(5):325-40
pubmed: 7963785
Ann Oncol. 2013 Apr;24(4):895-900
pubmed: 23175625
Crit Rev Oncol Hematol. 2008 Feb;65(2):143-55
pubmed: 18068997
J Psychosoc Oncol. 2008;26(1):31-51
pubmed: 18077261
Oncologist. 2009 Sep;14(9):891-9
pubmed: 19738000
J Affect Disord. 2009 Feb;113(1-2):127-32
pubmed: 18558439
Am Fam Physician. 2002 Mar 1;65(5):883-90
pubmed: 11898960
Psychooncology. 2017 Oct;26(10):1484-1490
pubmed: 27195436
N Engl J Med. 2012 Apr 5;366(14):1310-8
pubmed: 22475594
Crit Rev Oncol Hematol. 2003 Nov;48(2):185-97
pubmed: 14607382
Assessment. 2020 Oct;27(7):1383-1398
pubmed: 29947548
Cancer Epidemiol. 2014 Jun;38(3):214-26
pubmed: 24768601
Cancer. 2008 Aug 15;113(4):879-86
pubmed: 18521903
J Affect Disord. 2012 Dec 10;141(2-3):343-51
pubmed: 22727334
J Gerontol Soc Work. 2006;47(1-2):17-25
pubmed: 16901875
Cancer Pract. 2001 Jan-Feb;9(1):11-8
pubmed: 11879268
Am J Geriatr Psychiatry. 2005 Mar;13(3):195-201
pubmed: 15728750
Psychooncology. 2014 Sep;23(9):1034-41
pubmed: 24711163
Br J Psychiatry. 1999 Apr;174:312-21
pubmed: 10533550
J Natl Cancer Inst Monogr. 2004;(32):150-7
pubmed: 15263059
J Clin Oncol. 2008 Oct 10;26(29):4731-8
pubmed: 18695257
J Clin Oncol. 2008 Oct 10;26(29):4720-4
pubmed: 18695256
Harv Rev Psychiatry. 2018 Nov/Dec;26(6):352-363
pubmed: 30407234
J Geriatr Oncol. 2019 Sep;10(5):680-684
pubmed: 30797709
J Gerontol. 1991 Nov;46(6):M210-5
pubmed: 1834726
Cancer. 2019 Mar 15;125(6):972-979
pubmed: 30613943
Breast. 2010 Apr;19(2):84-91
pubmed: 20042336
Cancer Treat Rev. 2017 May;56:16-27
pubmed: 28453966
Oncology (Williston Park). 2019 Nov 14;33(11):
pubmed: 31769862
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
J Clin Oncol. 2005 Dec 1;23(34):8671-8
pubmed: 16314627
J Public Health Res. 2021 May 05;10(3):
pubmed: 33960184
Psychiatr Clin North Am. 2002 Dec;25(4):685-98
pubmed: 12462855
Br J Cancer. 2008 Jun 17;98(12):1934-43
pubmed: 18506146
Int J Geriatr Psychiatry. 2011 Jan;26(1):21-6
pubmed: 21157847
Psychosomatics. 2009 Jul-Aug;50(4):383-91
pubmed: 19687179
J Affect Disord. 2011 Mar;129(1-3):126-42
pubmed: 20926139
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Cancer J. 2005 Nov-Dec;11(6):437-41
pubmed: 16393477
J Health Soc Behav. 2009 Mar;50(1):31-48
pubmed: 19413133
Support Care Cancer. 1996 Mar;4(2):129-40
pubmed: 8673350
Arch Intern Med. 2000 Jul 24;160(14):2101-7
pubmed: 10904452
Arch Gen Psychiatry. 1993 Sep;50(9):681-9
pubmed: 8357293
Health Psychol. 2004 Nov;23(6):564-73
pubmed: 15546224
Nat Commun. 2019 Jan 14;10(1):207
pubmed: 30643135
Cancer. 1994 Nov 1;74(9):2570-8
pubmed: 7923013
J Clin Oncol. 2002 Apr 1;20(7):1907-17
pubmed: 11919251
Psychooncology. 2015 Jun;24(6):712-7
pubmed: 25099337
J Psychiatr Res. 1982-1983;17(1):37-49
pubmed: 7183759
J Psychosom Res. 2000 Feb;48(2):171-5
pubmed: 10719134
J Geriatr Oncol. 2018 Sep;9(5):476-481
pubmed: 29650403
J Clin Oncol. 2004 Oct 15;22(20):4209-16
pubmed: 15483032
Am J Psychiatry. 2005 Jan;162(1):178-80
pubmed: 15625218
Psychosomatics. 2006 Sep-Oct;47(5):376-84
pubmed: 16959925
JAMA Psychiatry. 2019 Jan 1;76(1):51-60
pubmed: 30476945
Epidemiol Prev. 2012 Mar-Apr;36(2):83-7
pubmed: 22706357
JAMA Intern Med. 2015 Feb;175(2):307-9
pubmed: 25506678
Psychooncology. 2014 Feb;23(2):121-30
pubmed: 24105788
Eur J Cancer Prev. 2017 Sep;26 Joining forces for better cancer registration in Europe:S197-S203
pubmed: 28914692
Int J Cancer. 2018 May 15;142(10):1986-1993
pubmed: 29250783
Expert Rev Hematol. 2009 Feb;2(1):69-80
pubmed: 21082996
Ann Intern Med. 2002 Mar 5;136(5):349-57
pubmed: 11874307
Psychol Aging. 2002 Sep;17(3):379-91
pubmed: 12243380
Support Care Cancer. 2012 Nov;20(11):2795-802
pubmed: 22350596
CA Cancer J Clin. 2015 Sep-Oct;65(5):339-44
pubmed: 26208318
J Natl Cancer Inst Monogr. 2004;(32):80-92
pubmed: 15263046
Psychooncology. 2015 May;24(5):601-7
pubmed: 25336020
J Gerontol. 1994 Nov;49(6):P251-64
pubmed: 7963280
J Gerontol A Biol Sci Med Sci. 2003 Mar;58(3):249-65
pubmed: 12634292
J Affect Disord. 2002 Dec;72(3):227-36
pubmed: 12450639
Br J Psychiatry. 1999 Apr;174:307-11
pubmed: 10533549
Psychol Med. 2010 Nov;40(11):1797-810
pubmed: 20085667
J Clin Oncol. 2008 Oct 10;26(29):4725-30
pubmed: 18695258
Breast Cancer Res Treat. 2017 Nov;166(1):267-275
pubmed: 28726159
JAMA. 2017 May 23;317(20):2114-2122
pubmed: 28535241
Clin Pract Epidemiol Ment Health. 2020 Jul 30;16:174-179
pubmed: 32874192
Am J Geriatr Psychiatry. 2005 Oct;13(10):852-60
pubmed: 16223963
J Affect Disord. 2012 Dec 15;142(1-3):172-9
pubmed: 22940498
J Am Geriatr Soc. 1997 May;45(5):570-8
pubmed: 9158577
Br J Psychiatry. 2012 Apr;200(4):275-81
pubmed: 22474233
J Gerontol A Biol Sci Med Sci. 2004 Jan;59(1):24-33
pubmed: 14718483
Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):2097-105
pubmed: 20696665
Lancet Oncol. 2011 Feb;12(2):160-74
pubmed: 21251875
Am J Public Health. 1997 Mar;87(3):434-7
pubmed: 9096548
J Geriatr Oncol. 2020 Jun;11(5):814-819
pubmed: 31787493
Int J Geriatr Psychiatry. 2012 Jun;27(6):601-11
pubmed: 21773997
Psychogeriatrics. 2018 Sep;18(5):365-370
pubmed: 29998465
Am J Geriatr Psychiatry. 2005 Jul;13(7):589-96
pubmed: 16009735
JAMA. 2005 Dec 7;294(21):2703-11
pubmed: 16333005